108 related articles for article (PubMed ID: 21317442)
21. Why people do not take their psychotropic drugs as prescribed: results of the 2000 National Psychiatric Morbidity Survey.
Cooper C; Bebbington P; King M; Brugha T; Meltzer H; Bhugra D; Jenkins R
Acta Psychiatr Scand; 2007 Jul; 116(1):47-53. PubMed ID: 17559600
[TBL] [Abstract][Full Text] [Related]
22. [Psychotropic medications use in Spain. Results of the ESEMeD-Spain study].
Codony M; Alonso J; Almansa J; Vilagut G; Domingo A; Pinto-Meza A; Fernández A; Serrano-Blanco A; Márquez M; Haro JM
Actas Esp Psiquiatr; 2007 Sep; 35 Suppl 2():29-36. PubMed ID: 18264867
[TBL] [Abstract][Full Text] [Related]
23. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
[TBL] [Abstract][Full Text] [Related]
24. Patterns of psychotropic medicine use and related diseases across educational groups: national cross-sectional survey.
Nielsen MW; Hansen EH; Rasmussen NK
Eur J Clin Pharmacol; 2004 May; 60(3):199-204. PubMed ID: 15024533
[TBL] [Abstract][Full Text] [Related]
25. Psychotropic prescribing in Catalonia: results from an epidemiological study.
Rubio-Valera M; Fernández A; Luciano JV; Hughes CM; Pinto-Meza A; Moreno-Küstner B; Palao DJ; Haro JM; Serrano-Blanco A
Fam Pract; 2012 Apr; 29(2):154-62. PubMed ID: 21926053
[TBL] [Abstract][Full Text] [Related]
26. Characteristics associated with use of homeopathic drugs for psychiatric symptoms in the general population.
Grolleau A; Bégaud B; Verdoux H
Eur Psychiatry; 2013 Feb; 28(2):110-6. PubMed ID: 22153728
[TBL] [Abstract][Full Text] [Related]
27. The influence of prescription drug insurance on psychotropic and non-psychotropic drug utilization in Canada.
Sarma S; Basu K; Gupta A
Soc Sci Med; 2007 Dec; 65(12):2553-65. PubMed ID: 17761377
[TBL] [Abstract][Full Text] [Related]
28. Insurance coverage and the treatment of mental illness: effect on medication and provider use.
Mulvale G; Hurley J
J Ment Health Policy Econ; 2008 Dec; 11(4):177-99. PubMed ID: 19096092
[TBL] [Abstract][Full Text] [Related]
29. Mental Illness and Psychotropic Medication use Among People Assessed for Bariatric Surgery in Ontario, Canada.
Hensel J; Selvadurai M; Anvari M; Taylor V
Obes Surg; 2016 Jul; 26(7):1531-6. PubMed ID: 26450710
[TBL] [Abstract][Full Text] [Related]
30. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness.
Haw C; Stubbs J
J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284
[TBL] [Abstract][Full Text] [Related]
31. The appropriateness of psychotropic medicines: an interview study of service users attending a substance misuse service in England.
Oluyase AO; Raistrick D; Hughes E; Lloyd C
Int J Clin Pharm; 2019 Aug; 41(4):972-980. PubMed ID: 31197547
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration.
Barry DT; Sofuoglu M; Kerns RD; Wiechers IR; Rosenheck RA
Psychiatry Res; 2015 Jun; 227(2-3):324-32. PubMed ID: 25863822
[TBL] [Abstract][Full Text] [Related]
33. A community survey of psychotropic drug consumption in South Verona: prevalence and associated variables.
Turrina C; Zimmermann-Tansella C; Micciolo R; Siciliani O
Soc Psychiatry Psychiatr Epidemiol; 1993 Feb; 28(1):40-4. PubMed ID: 8465241
[TBL] [Abstract][Full Text] [Related]
34. Medication use in US youth with mental disorders.
Merikangas KR; He JP; Rapoport J; Vitiello B; Olfson M
JAMA Pediatr; 2013 Feb; 167(2):141-8. PubMed ID: 23403911
[TBL] [Abstract][Full Text] [Related]
35. The prescribing of psychotropic drugs in mental health services in Trinidad.
Moore S; Jaime LK; Maharajh H; Ramtahal I; Reid S; Ramsewak FS; Maharaj M
Rev Panam Salud Publica; 2002 Sep; 12(3):207-14. PubMed ID: 12396640
[TBL] [Abstract][Full Text] [Related]
36. Factors Associated With Psychotropic Medication Use in Individuals in Brazilian Primary Health Care Units: A Descriptive, Cross-Sectional Study.
Filho PC; Borges TL; Pereira AD; Vedana KG; Shasanmi RO; Gimenes FR; Miasso AI
J Psychosoc Nurs Ment Health Serv; 2017 Mar; 55(3):38-45. PubMed ID: 28287674
[TBL] [Abstract][Full Text] [Related]
37. Nurses' attitudes towards the use of PRN psychotropic medications in acute and forensic mental health settings.
Barr L; Wynaden D; Heslop K
Int J Ment Health Nurs; 2018 Feb; 27(1):168-177. PubMed ID: 28337845
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65.
Qian J; Wittayanukorn S; McGuffey G; Hansen R
Disabil Health J; 2015 Jul; 8(3):424-33. PubMed ID: 25890881
[TBL] [Abstract][Full Text] [Related]
39. Use of psychotropic medication in the general population of France, Germany, Italy, and the United Kingdom.
Ohayon MM; Lader MH
J Clin Psychiatry; 2002 Sep; 63(9):817-25. PubMed ID: 12363124
[TBL] [Abstract][Full Text] [Related]
40. Use and cost of psychotropic drugs among recipients with autism in a state Medicaid fee-for-service programme.
Khanna R; Jariwala K; West-Strum D
J Intellect Disabil Res; 2013 Feb; 57(2):161-71. PubMed ID: 22471524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
